Europe — EMA
Orlistato Zentiva
Orlistat, the active ingredient in Orlistato Zentiva, is a Lip Lip presented as a 120mg tablet for oral use. It inhibits intestinal fat absorption and is indicated for weight management in overweight and obese adults.
Request sourcing
What is Orlistat?
Orlistat, the active ingredient in Orlistato Zentiva, is a Lip Lip presented as a 120mg tablet for oral use. It inhibits intestinal fat absorption and is indicated for weight management in overweight and obese adults.
GNH USA supplies Orlistato Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Orlistat used for?
Orlistat is used in the management of obesity and related metabolic conditions. It helps: - Obesity: Reduces body weight by decreasing dietary fat absorption. - Overweight adults with additional risk factors: Supports weight loss when combined with a reduced‑calorie diet. - Post‑bariatric surgery patients: Assists in maintaining weight loss after surgical intervention.
What are the side effects of Orlistat?
Adverse reactions are generally related to the drug’s mechanism of reducing fat absorption.
Common Side Effects: - Oily spotting on undergarments. - Increased bowel movements. - Fecal urgency. - Flatulence with discharge. - Abdominal cramping. - Loose, oily stools.
Serious or Rare Side Effects: - Severe liver injury. - Acute pancreatitis. - Allergic reactions such as rash, itching or swelling. - Persistent gastrointestinal bleeding. - Vitamin D deficiency due to malabsorption. - Kidney stones. - Unexplained weight loss. - Severe abdominal pain. - Jaundice. - Anaphylaxis. - Hepatotoxic - -
What precautions apply to Orlistat?
Orlistat should be taken g
t t \
